Skip to main content
. 2024 Jul 10;14:1438731. doi: 10.3389/fonc.2024.1438731

Figure 1.

Figure 1

Use RNA-ISH technology to enrich and analyze CTCs in blood samples of HCC patients (A) The expression of epithelial marker mRNA (EpCAM and E-cadherin) and (B) mesenchymal marker mRNA (Twist and vimentin) and CSC marker mRNA (nanog) were validated by qPCR, p<0.05; (C) The protein expression levels of epithelial markers (EpCAM and E-cadherin), p<0.001. (D–G) The total number of CTCs, epithelial CTCs, mixed CTCs, and mesenchymal CTCs correlated with BCLC staging, p<0.05. **represents P<0.01, *represents P<0.05.